1. U.S. Government Accountability Office. Food and Drug Administration: Decision process to deny initial application for over-the-counter marketing of the emergency contraceptive drug Plan B was unusual. https://www.gao.gov/products/gao-06-109; 2005. [Accessed 25 November 2021].
2. FDA. Center for Drug Evaluation and Research. Nonprescription Drugs Advisory Committee (NDAC) in joint session with the Advisory Committee for Reproductive Health Drugs (ACRHD). Meeting transcript. December 16, 2003.
3. Images of American sexuality in debates over nonprescription access to emergency contraceptive pills;Wynn;Obstet Gynecol,2006
4. The social life of emergency contraception in the United States: disciplining pharmaceutical use, disciplining sexuality, and constructing zygotic bodies;Wynn;Med Anthropol Quart,2006
5. Committee Opinion No 579